Tci Wealth Advisors, Inc. Verastem, Inc. Transaction History

Tci Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$2.54 - $4.07 $2,103 - $3,369	-828 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$2.57 - $4.85 $2,127 - $4,015	828 New	828 $3,000
Q2 2019 Jul 23, 2019	SELL	$1.25 - $3.14 $272 - $684	-218 Closed	0 $0
Q4 2018 Jan 17, 2019	SELL	$3.23 - $7.01 $406 - $883	-126 Reduced 36.63%	218 $1,000
Q2 2018 Jul 27, 2018	BUY	$2.88 - $8.67 $362 - $1,092	126 Added 57.8%	344 $2,000
Q1 2018 Apr 30, 2018	BUY	$2.92 - $3.81 $143 - $186	49 Added 28.99%	218 $1,000
Q4 2017 Feb 01, 2018	BUY	$2.99 - $4.85 $505 - $819	169	169 $1,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $628M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.